5001-45-6

Basic information

• Product Name: (+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID
• Synonyms: (+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID
• CAS NO: 5001-45-6
• Molecular Formula: C16H9N5O11
• Molecular Weight: 447.27
• Mol File: 5001-45-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID(5001-45-6)
• EPA Substance Registry System: (+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID(5001-45-6)

Safety Data

• Hazardous Substances Data: 5001-45-6(Hazardous Substances Data)

Usage

Uses

Used in Explosive Materials Industry:
(+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID is used as a sensitizing agent for enhancing the reactivity of explosive materials. Its incorporation into these materials serves to lower the energy threshold required for detonation, making the explosives more sensitive and responsive to initiating stimuli.
Due to its highly reactive and potentially explosive nature, (+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID must be handled and stored with extreme care and caution to prevent accidental detonation or decomposition. This requirement underscores the need for stringent safety protocols in industries where (+),(-)-A-2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXYPROPIONIC ACID is utilized.

Upstream product

• 2009-88-3 α-(isopropylidenaminooxy)-propionic acid 
• 746-53-2 2,4,5,7-tetranitrofluoren-9-one 
• 2009-89-4 (S)-2-isopropylidenaminooxy-propionic acid 
• 2009-88-3 (R)-2-isopropylidenaminooxy-propionic acid 
• 67-56-1 methanol 

Downstream Products

• 187-83-7 <6> helicene 

Relevant articles and documents

Camptothecin derivatives as chemoradiosensitizing agents

Camptothecin-based compounds are useful for treating a neoplasm in mammalian subjects by administering such compound to the subjects in combination with radiotherapy, i.e., the treatment of tumors with radioactive substances or radiation from a source external to the subject. Camptothecin-based compounds are modified by positioning at least one electron-affinic group around the camptothecin structure to enhance their value in combination with radiotherapy. New Camptothecin-based compounds are disclosed that are useful for treating cancer by administering the novel compounds alone or in combination with radiotherapy.

Application of NMR Spectroscopy of Chiral Association Complexes. 13.Electron Donor-acceptor Complexes between Racemic Carbazolocarbazoles and an Optically Active Acceptor

Strong electron donor-acceptor (EDA) asociation between carbazolocarbazoles and an optically active tetranitrofluorenone derivative was detected by UV-visible spectroscopy and by 1H NMR shifts. 1H NMR splitting at low temperatures are due ti diastereomeric association complexes and, thus, prove the chirality of carbazolocarbazoles.